Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Laser Vaccine Adjuvants
>  Cancer Monitoring Technology
>  Drug Addiction Treatment
  March 2020   e-Newsletter Advertise | Editorial Calendar  
Catalent
Latest e-book
News
CytomX Therapeutics and Astellas Announce...
Sorrento And Smartpharm...
Press Releases
Eisai to Launch Digital Tool "NouknowTM"...
CNS Pharmaceuticals Signs Agreement...
Events
30 - 31 Mar 2020
World Nursing Care Congress 2020
14 - 16 Apr 2020
MASS East 2020
27 - 28 May 2020
Chemspec Europe 2020
Articles
>  Laser Vaccine Adjuvants
Alex Nivorozhkin, CEO, Alternative Innovative Technologies LLC, Boston, MA, USA
Recent medical research has proved that low power nondestructive lasers boost vaccine immune response for most threatening infections of our time. Enabled by recently developed inexpensive devices and involving just a minute-long treatment, this novel approach breaks existing stereotypes and appears ready for wide clinical testing and practice.Vaccine adjuvants represent an essential tool to augment human immune response. Despite significant advances in medical research...
Techno Trends
> Personalized Cancer Monitoring Technology Launched to Treat Cancer...
> Novel Potential Target Discovered for Drug Addiction Treatment...
> Aprea Therapeutics to Treat Myelodysplastic Syndromes
Projects
> Piramal Pharma to Expand its Aurora Facility in Canada
> Merck Invests in New Biotech Development Facility in Switzerland
> Philips-Medisize Expands its Denmark Site
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.